Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Goldman Sachs cut Genuine Parts Company (NYSE:GPC) price target from $133 to $114. Goldman Sachs analyst Kate McShane downgraded the stock from Neutral to Sell. Genuine Parts shares closed at $119.14 on Monday. See how other analysts view this stock.
- Needham slashed the price target for Vaxcyte, Inc. (NASDAQ:PCVX) from $140 to $90. Needham analyst Joseph Stringer maintained a Buy rating. Vaxcyte shares closed at $37.76 on Monday. See how other analysts view this stock.
- Goldman Sachs raised Ulta Beauty, Inc. (NASDAQ:ULTA) price target from $384 to $423. Goldman Sachs analyst Kate McShane upgraded the stock from Neutral to Buy. Ulta Beauty shares closed at $366.54 on Monday. See how other analysts view this stock.
- TD Securities increased the price target for First Watch Restaurant Group, Inc. (NASDAQ:FWRG) from $21 to $22. TD Securities analyst Andrew Charles upgraded the stock from Hold to Buy. First Watch Restaurant shares closed at $16.65 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. raised the price target for BiomX Inc. (NYSE:PHGE) from $2 to $21. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. BiomX shares closed at $0.5557 on Monday. See how other analysts view this stock.
- D. Boral Capital cut Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) price target from $15 to $8. D. Boral Capital analyst Jason Kolbert maintained a Buy rating. Reviva Pharmaceuticals shares settled at $0.9538 on Monday. See how other analysts view this stock.
- Mizuho cut PBF Energy Inc. (NYSE:PBF) price target from $28 to $22. Mizuho analyst Nitin Kumar maintained an Underperform rating. PBF Energy shares closed at $19.09 on Monday. See how other analysts view this stock.
- B of A Securities raised Travere Therapeutics, Inc. (NASDAQ:TVTX) price target from $29 to $31. B of A Securities analyst Greg Harrison maintained a Buy rating. Travere Therapeutics shares closed at $17.92 on Monday. See how other analysts view this stock.
- B of A Securities slashed the price target for Knight-Swift Transportation Holdings Inc. (NYSE:KNX) from $66 to $46. B of A Securities analyst Ken Hoexter downgraded the stock from Buy to Neutral. Knight-Swift Transportation shares settled at $43.49 on Monday. See how other analysts view this stock.
- Jefferies cut Delta Air Lines, Inc. (NYSE:DAL) price target from $85 to $46. Jefferies analyst Sheila Kahyaoglu downgraded the stock from Buy to Hold. Delta Air shares closed at $43.60 on Monday. See how other analysts view this stock.
Considering buying ULTA stock? Here’s what analysts think:
Photo via Shutterstock
